Ibuprofen

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including headache, muscular aches, minor pain of arthritis, toothache, backache, the common cold, and menstrual cramps. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Patients should adhere strictly to the recommended dosage and not exceed the directed amount. The smallest effective dose should be utilized to manage symptoms effectively.

For adults and children aged 12 years and older, the recommended dosage is 1 tablet every 4 to 6 hours as needed while symptoms persist. In cases where pain or fever does not adequately respond to 1 tablet, a dose of 2 tablets may be administered. However, it is imperative that the total daily dosage does not exceed 6 tablets within a 24-hour period, unless otherwise directed by a healthcare professional.

For children under the age of 12, it is advised to consult a doctor for appropriate dosing recommendations.

Contraindications

Use is contraindicated in patients with a history of allergic reactions to ibuprofen or any other pain reliever or fever reducer. Additionally, administration is contraindicated immediately before or after heart surgery due to potential complications associated with surgical recovery.

Warnings and Precautions

Ibuprofen is associated with several important warnings and precautions that healthcare professionals should be aware of to ensure safe use in patients.

Allergic Reactions Ibuprofen may induce severe allergic reactions, particularly in individuals with a known allergy to aspirin. Symptoms indicative of an allergic response may include hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, and blisters. In the event of an allergic reaction, it is imperative to discontinue use immediately and seek medical assistance.

Overdose In cases of suspected overdose, it is crucial to obtain emergency medical help or contact a Poison Control Center without delay. The national Poison Control Center can be reached at 1-800-222-1222.

Gastrointestinal and Cardiovascular Monitoring Patients should be advised to stop taking ibuprofen and contact their healthcare provider if they experience any signs of stomach bleeding, which may manifest as feeling faint, vomiting blood, having bloody or black stools, or experiencing persistent stomach pain. Additionally, symptoms suggestive of heart problems or stroke, such as chest pain, difficulty breathing, unilateral weakness, slurred speech, or leg swelling, warrant immediate medical evaluation.

Duration of Symptoms Healthcare professionals should instruct patients to seek medical advice if pain worsens or persists beyond 10 days, or if fever intensifies or lasts more than 3 days, particularly if accompanied by redness or swelling in the affected area. Any emergence of new symptoms should also prompt a consultation with a healthcare provider.

These precautions are essential for the safe administration of ibuprofen and to mitigate potential adverse effects.

Side Effects

Patients may experience a range of adverse reactions while using ibuprofen, which can be categorized by seriousness and frequency.

Severe allergic reactions have been reported, particularly in individuals with a known allergy to aspirin. Symptoms of such reactions may include hives, facial swelling, asthma (wheezing), shock, skin reddening, rash, and blisters. Patients experiencing any of these symptoms should seek immediate medical attention.

Gastrointestinal complications may arise, necessitating the cessation of ibuprofen and consultation with a healthcare provider if any of the following signs of stomach bleeding occur: feeling faint, vomiting blood, having bloody or black stools, or experiencing stomach pain that does not improve.

Cardiovascular and neurological symptoms warrant immediate medical evaluation. Patients should stop using ibuprofen and consult a doctor if they experience chest pain, difficulty breathing, weakness on one side of the body, slurred speech, or leg swelling, as these may indicate heart problems or stroke.

In clinical trials, it was noted that pain persisting beyond 10 days or fever worsening or lasting more than 3 days, especially when accompanied by redness or swelling in the affected area, should prompt a consultation with a healthcare professional. Additionally, any new symptoms that arise during treatment should be discussed with a doctor.

Patients with a history of serious side effects from pain relievers or fever reducers, those with stomach problems such as heartburn, or individuals with conditions like high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or a history of stroke should consult a healthcare provider before using ibuprofen. Furthermore, patients taking diuretics or aspirin for heart attack or stroke should seek medical advice, as ibuprofen may diminish the cardioprotective effects of aspirin.

Overall, careful monitoring for these adverse reactions is essential to ensure patient safety during ibuprofen therapy.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Ibuprofen. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is 1 tablet every 4 to 6 hours as needed for symptom relief. If pain or fever does not adequately respond to 1 tablet, 2 tablets may be administered. It is important not to exceed 6 tablets within a 24-hour period unless otherwise directed by a healthcare provider.

Geriatric Use

Elderly patients, particularly those aged 60 and older, are at an increased risk for severe stomach bleeding when using this medication. It is essential for healthcare providers to exercise caution and consider this heightened risk when prescribing to geriatric patients.

Additionally, the risk of serious cardiovascular events, including heart attack, heart failure, and stroke, is elevated in older adults, especially when the medication is used in excess of the recommended dosage or for prolonged periods. Therefore, careful monitoring and adherence to prescribed dosages are crucial in this population.

Healthcare providers are advised to recommend that patients aged 60 and older consult with their physician prior to use, particularly if they have concerns related to the stomach bleeding warning. This precautionary measure is vital to ensure the safety and well-being of elderly patients receiving this treatment.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. It is particularly important to avoid the use of ibuprofen after 20 weeks of pregnancy unless specifically directed by a physician, as it may pose risks to the developing fetus and lead to complications during delivery. Healthcare providers should carefully evaluate the potential benefits and risks when considering the use of this medication in pregnant patients.

Lactation

Lactating mothers are advised to consult a healthcare professional before using this medication while breastfeeding. It is particularly important to avoid the use of ibuprofen at 20 weeks of gestation or later unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery. There is no specific data provided regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when considering its use in lactating individuals.

Renal Impairment

There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted in these patients to ensure safety and therapeutic effectiveness.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, increased severity of known side effects, unusual behavioral changes, or any other atypical clinical manifestations.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for specific guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, healthcare professionals should exercise caution, remain observant for potential overdose symptoms, and implement appropriate management strategies as needed.

Nonclinical Toxicology

It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor, as it may cause problems in the unborn child or complications during delivery. No specific non-teratogenic effects have been identified in the available data. Additionally, there are no details regarding nonclinical toxicology or animal pharmacology and toxicology provided in the text.

Postmarketing Experience

Postmarketing experience has revealed reports of serious adverse reactions, including cardiovascular events such as heart attack and stroke. Additionally, gastrointestinal complications have been noted, including bleeding, ulceration, and perforation. Severe allergic reactions, such as anaphylaxis and angioedema, have also been reported.

Liver-related issues, including elevations in liver enzymes and instances of liver failure, have been documented. Renal toxicity has been observed, encompassing acute kidney injury and interstitial nephritis. Furthermore, skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported. Hematologic reactions, such as thrombocytopenia and aplastic anemia, have also been identified in the postmarketing data.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 in the event of an overdose. It is crucial for patients to understand the importance of prompt action in such situations.

Additionally, healthcare providers should recommend that patients take the medication with food or milk if they experience any stomach upset. This guidance can help mitigate gastrointestinal discomfort and enhance the overall tolerability of the treatment.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 20 to 25°C (68 to 77°F), in accordance with USP Controlled Room Temperature guidelines. Care should be taken to avoid exposure to excessive heat, specifically temperatures exceeding 40°C (104°F), to maintain product integrity. Proper storage conditions are crucial for ensuring the efficacy and safety of the product.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is particularly crucial to avoid ibuprofen after 20 weeks of pregnancy unless specifically directed by a physician, as it may pose risks to the unborn child or lead to complications during delivery.

Drug Information (PDF)

This file contains official product information for Ibuprofen, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)